MARC details
000 -LEADER |
fixed length control field |
05172cam a2200865Ka 4500 |
001 - |
control field |
ocn746326254 |
003 - |
control field |
OCoLC |
005 - |
control field |
20200709135938.0 |
006 - |
fixed length control field |
m o d |
007 - |
fixed length control field |
cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
110811s2011 njua ob 001 0 eng d |
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
Canceled/invalid LC control number |
2010023283 |
040 ## - |
-- |
DG1 |
-- |
eng |
-- |
pn |
-- |
DG1 |
-- |
CDX |
-- |
YDXCP |
-- |
N$T |
-- |
E7B |
-- |
OCLCQ |
-- |
EBLCP |
-- |
OCLCO |
-- |
OCLCQ |
-- |
OCLCF |
-- |
OCLCA |
-- |
OCLCQ |
-- |
IDEBK |
-- |
OCLCQ |
-- |
MHW |
-- |
UKDOC |
-- |
NLGGC |
-- |
OCLCQ |
-- |
COO |
-- |
OCLCQ |
-- |
DEBBG |
-- |
AZK |
019 ## - |
-- |
748534035 |
-- |
756501436 |
-- |
770866893 |
-- |
961512949 |
-- |
962579040 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780470921371 |
Qualifying information |
(electronic bk.) |
|
International Standard Book Number |
0470921374 |
Qualifying information |
(electronic bk.) |
|
International Standard Book Number |
9780470921364 |
Qualifying information |
(electronic bk.) |
|
International Standard Book Number |
0470921366 |
Qualifying information |
(electronic bk.) |
|
-- |
9780470386187 |
|
-- |
0470386185 |
|
-- |
9780470922972 |
|
-- |
0470922974 |
029 1# - |
-- |
AU@ |
-- |
000047980921 |
|
-- |
DKDLA |
-- |
820120-katalog:000573118 |
|
-- |
NZ1 |
-- |
15915585 |
|
-- |
DEBBG |
-- |
BV043393405 |
035 ## - |
-- |
(OCoLC)746326254 |
-- |
(OCoLC)748534035 |
-- |
(OCoLC)756501436 |
-- |
(OCoLC)770866893 |
-- |
(OCoLC)961512949 |
-- |
(OCoLC)962579040 |
037 ## - |
-- |
10.1002/9780470921371 |
-- |
Wiley InterScience |
-- |
http://www3.interscience.wiley.com |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
-- |
RS189.5.S65 |
-- |
C53 2011 |
060 #4 - |
-- |
2011 G-724 |
|
-- |
QV 25 |
072 #7 - |
-- |
MED |
-- |
023000 |
-- |
bisacsh |
|
-- |
MED |
-- |
058170 |
-- |
bisacsh |
|
-- |
MED |
-- |
071000 |
-- |
bisacsh |
|
-- |
MED |
-- |
072000 |
-- |
bisacsh |
082 04 - |
Classification number |
615/.1 |
-- |
22 |
049 ## - |
-- |
MAIN |
245 00 - TITLE STATEMENT |
Title |
Characterization of impurities and degradants using mass spectrometry / |
Statement of responsibility, etc |
edited by Birendra N. Pramanik, Mike S. Lee, Guodong Chen. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 online resource (xxii, 462 pages) : |
Other physical details |
illustrations. |
505 0# - |
Formatted contents note |
Frontmatter -- Methodology. Introduction to Mass Spectrometry / Scott A Smith, Ruth Waddell Smith, Yu Xia, Zheng Ouyang -- LC Method Development and Strategies / Gang Xue, Yining Zhao -- Rapid Analysis of Drug-Related Substances Using Desorption Electrospray Ionization and Direct Analysis in Real Time Ionization Mass Spectrometry / Hao Chen, Jiwen Li -- Orbitrap High-Resolution Applications / Robert J Strife -- Structural Characterization of Impurities and Degradation Products in Pharmaceuticals Using High-Resolution LC-MS and Online Hydrogen/Deuterium Exchange Mass Spectrometry / Guodong Chen, Birendra N Pramanik -- Isotope Patten Recognition on Molecular Formula Determination for Structural Identification of Impurities / Ming Gu -- Application. Practical Application of Very High-Pressure Liquid Chromatography across the Pharmaceutical Development₆Manufacturing Continuum / Brent Kleintop, Qinggang Wang -- Impurity Identification for Drug Substances / David W Berberich, Tao Jiang, Joseph McClurg, Frank Moser, R Randy Wilhelm -- Impurity Identification in Process Chemistry by Mass Spectrometry / David Q Liu, Mingjiang Sun, Lianming Wu -- Structure Elucidation of Pharmaceutical Impurities and Degradants in Drug Formulation Development / Changkang Pan, Frances Liu, Michael Motto -- Investigation of Degradation Products and Extractables in Developing Topical OTC (Over the Counter) and NCE (New Chemical Entity) Consumer Healthcare Medication Products / Fa Zhang -- Characterization of Impurities and Degradants in Protein Therapeutics by Mass Spectrometry / Li Tao, Michael Ackerman, Wei Wu, Peiran Liu, Reb Russell -- Identification and Quantification of Degradants and Impurities in Antibodies / David M Hambly, Himanshu S Gadgil -- Index. |
650 #0 - |
Topical term or geographic name as entry element |
Drugs |
|
Topical term or geographic name as entry element |
Drugs |
|
Topical term or geographic name as entry element |
Mass spectrometry. |
|
Topical term or geographic name as entry element |
Contamination (Technology) |
|
Topical term or geographic name as entry element |
Mass Spectrometry |
|
Topical term or geographic name as entry element |
Pharmaceutical Preparations |
|
Topical term or geographic name as entry element |
Drug Contamination. |
|
Topical term or geographic name as entry element |
MEDICAL |
|
Topical term or geographic name as entry element |
MEDICAL |
|
Topical term or geographic name as entry element |
MEDICAL |
|
Topical term or geographic name as entry element |
MEDICAL |
|
Topical term or geographic name as entry element |
Contamination (Technology) |
|
Topical term or geographic name as entry element |
Drugs |
|
Topical term or geographic name as entry element |
Drugs |
|
Topical term or geographic name as entry element |
Mass spectrometry. |
700 1# - |
Personal name |
Pramanik, Birendra N., |
|
Personal name |
Lee, Mike S., |
|
Personal name |
Chen, Guodong. |
710 2# - |
Corporate name or jurisdiction name as entry element |
Wiley InterScience (Online service) |
856 40 - |
Uniform Resource Identifier |
https://doi.org/10.1002/9780470921371 |
264 #1 - |
-- |
Hoboken, N.J. : |
-- |
John Wiley, |
-- |
[2011] |
|
-- |
©2011 |
336 ## - |
-- |
text |
-- |
txt |
-- |
rdacontent |
337 ## - |
-- |
computer |
-- |
c |
-- |
rdamedia |
338 ## - |
-- |
online resource |
-- |
cr |
-- |
rdacarrier |
347 ## - |
-- |
data file |
-- |
rda |
380 ## - |
-- |
Bibliography |
490 1# - |
-- |
Wiley series on pharmaceutical science and biotechnology |
504 ## - |
-- |
Includes bibliographical references and index. |
588 0# - |
-- |
Print version record. |
650 #0 - |
-- |
Analysis. |
|
-- |
Spectra. |
|
-- |
methods. |
|
-- |
analysis. |
|
-- |
Drug Guides. |
-- |
bisacsh |
|
-- |
Nursing |
-- |
Pharmacology. |
-- |
bisacsh |
|
-- |
Pharmacology. |
-- |
bisacsh |
|
-- |
Pharmacy. |
-- |
bisacsh |
|
-- |
fast |
-- |
(OCoLC)fst00876602 |
|
-- |
Analysis. |
-- |
fast |
-- |
(OCoLC)fst00898769 |
|
-- |
Spectra. |
-- |
fast |
-- |
(OCoLC)fst00898921 |
|
-- |
fast |
-- |
(OCoLC)fst01011435 |
655 #4 - |
-- |
Electronic books. |
700 1# - |
-- |
1944- |
|
-- |
1960- |
776 08 - |
-- |
Print version: |
-- |
Characterization of impurities and degradants using mass spectrometry. |
-- |
Hoboken, N.J. : John Wiley, ©2011 |
-- |
9780470386187 |
-- |
(DLC) 2010023283 |
-- |
(OCoLC)430842666 |
830 #0 - |
-- |
Wiley series on pharmaceutical science and biotechnology. |
856 40 - |
-- |
Wiley Online Library |
994 ## - |
-- |
92 |
-- |
DG1 |